Utility of infliximab therapy in severe enterorrhagia associated with Crohn's disease. Report of three cases;Utilidad del tratamiento con infliximab en la enterorragia severa asociada a la enfermedad de Crohn. Experiencia de tres casos

Gastroenterologia y Hepatologia

Volumn 34, Issue 1, 2011, Pages 24-28

  Alcalde Vargas, Alfonso ^a   Justiniano, José Manuel Herrera ^a   Carnerero, Eduardo Leo ^a   Salado, Claudio Trigo ^a   Domingo, Ignacio Gutiérrez ^a   Galán, José Luis Márquez ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

Biological agents; Crohn's disease; Lower gastrointestinal hemorrhage

Indexed keywords

INFLIXIMAB;

ARTICLE; BLOOD TRANSFUSION; CASE REPORT; CROHN DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; GASTROINTESTINAL HEMORRHAGE; HUMAN; TREATMENT OUTCOME;

ADULT; ANTIBODIES, MONOCLONAL; CROHN DISEASE; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; MALE; SEVERITY OF ILLNESS INDEX; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 79551472964     PISSN: 02105705     EISSN: 15789519     Source Type: Journal    
DOI: 10.1016/j.gastrohep.2010.09.004     Document Type: Article

References (14)

1. Belaiche J., Louis E. Severe lower gastrointestinal bleeding in Crohn's disease: successful control with infliximab. Am J Gastroenterol. 2002, 97:3210-3211.
2. Belaiche J., Louis E., D'Haens G., Cabooter M., Naegels S., De Vos M., et al. Acute lower gastrointestinal bleeding in Crohn's disease: characteristics of a unique series of 34 patients. Belgian IBD Research Group. Am J Gastroenterol. 1999, 94:2177-2181.
3. Papi C., Gili L., Tarquini M., Antonelli G., Capurso L. Infliximab for severe recurrent Crohn's disease presenting with massive gastrointestinal hemorrhage. J Clin Gastroenterol. 2003, 36:238-241.
4. Cirocco W.C., Reilly J.C., Rusin L.C. Life-threatening hemorrhage and exanguination from Crohn's disease. Report of four cases. Dis Colon Rectum. 1995, 38:85-95.
5. Meyer M.M., Levine E.J. Acute hemorrhagic Crohn's disease controlled with infliximab. Inflamm Bowel Dis. 2009, 15:1456-1457.
6. Berg D.F., Bahadursingh A.M., Kaminski D.L. Acute surgical emergencies in inflammatory bowel disease. Am J Surg. 2002, 184:45-51.
7. Modigliani R., Mary J.Y., Simon J.F., Cortot A., Soule J.C., Gendre J.P., et al. Clinical, biological, and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone. Gastroenterology. 1990, 98:811-818.
8. Rutgeerts P., Feagan B.G., Lichtenstein G.R., Mayer L.F., Schreiber S., Colombel J.F., et al. Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease. Gastroenterology. 2004, 126:402-413.
9. Bauditz J., Schachschal G., Wedel S., Lochs H. Thalidomide for treatment of severe intestinal bleeding. Gut. 2004, 53:609-612.
10. Girona E., Borras-Blaco J., Conesa-García V., Navarro-Ruiz A., Solis J., García-Sepulcre M.F., et al. Successful treatment of severe gastrointestinal bleeding secondary Crohn disease with recombinant factor VIIa. South Med J. 2007, 100:601-604.
11. Yugo Ando, Mitsunobu Matsushita, Seiji Kawamata, Masaaki Shimatani, Toshihito Fujii, Kazuichi Okazaki Infliximab for severe gastrointestinal bleeding in Crohn's disease. Inflamm Bowel Dis. 2009, 15:483-484.
12. D'Haens G., Noman M., Baert F., Hiele M. Endoscopic healing after infliximab treatment following Crohn's disease provides a longer time to relapse. Gastroenterology. 2002, 122:A100.
13. Colombel J.F., Rutgeerts P., Yan S., Bala M., Bao W., Olson A., et al. Infliximab maintenance treatment results in lower hospitalization rate in Crohn's disease patients. Gastroenterology. 2002, 122:A613.
14. Allez M., Lemann M., Bonnet J., Cattan P., Jian R., Modigliani Long term outcome of patients with active Crohn's disease exhibiting extensive and deep ulcerations at colonoscopy. Am J Gastroenterol. 2002, 97:947-953.